Literature DB >> 5015915

Immunological effects of BCG in malignant melanoma: two modes of administration compared.

A Z Bluming, C L Vogel, J L Ziegler, N Mody, G Kamya.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5015915     DOI: 10.7326/0003-4819-76-3-405

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

Review 1.  Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Authors:  E Lederer; A Adam; R Ciorbaru; J F Petit; J Wietzerbin
Journal:  Mol Cell Biochem       Date:  1975-05-30       Impact factor: 3.396

2.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

Review 3.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

4.  Immune therapy of malignant melanoma.

Authors: 
Journal:  Can Med Assoc J       Date:  1972-09-09       Impact factor: 8.262

5.  Immunological studies in Ugandan patients with hepatocellular carcinoma.

Authors:  A Primack; C L Vogel; L F Barker
Journal:  Br Med J       Date:  1973-01-06

6.  Editorial: BCG treatment of malignant melanoma.

Authors: 
Journal:  Can Med Assoc J       Date:  1974-02-02       Impact factor: 8.262

Review 7.  Mycobacterium.

Authors:  L Barksdale; K S Kim
Journal:  Bacteriol Rev       Date:  1977-03

Review 8.  Cancer immunotherapy.

Authors:  S P Richman; J U Gutterman; E M Hersh
Journal:  Can Med Assoc J       Date:  1979-02-03       Impact factor: 8.262

9.  Current status of immunotherapy of human cancers: leukaemias, lymphomas, solid tumours.

Authors:  G Mathé
Journal:  Drugs       Date:  1974       Impact factor: 9.546

10.  Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapy.

Authors:  V K Lui; J Karpuchas; P B Dent; P B McCulloch; M A Blajchman
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.